Funding Enables Six Commercial Biotechnology Product ProjectsCOLLEGE PARK, Md., April 27 -- The Mary...
Read more »
Funding Enables Six Commercial Biotechnology Product ProjectsCOLLEGE PARK, Md., April 27 -- The Mary...
Read more »
NEW YORK (AP) -- Shares of some top biotechnology companies are mixed at noon: Amgen fell $.32 or .5 percent, to $58.11. Biogen Idec rose $.18 or .3 percent, to $52.43. Celgene fell $.61 or 1.0 percent, to $58.40. Gilead Sciences fell $.13 or .3 percent, to $40.43.
Read more »
Funding Enables Six Commercial Biotechnology Product Projects
Read more »
NEW YORK (AP) -- Shares of some top biotechnology companies are up at 10 a.m.: Amgen rose $.25 or .4 percent, to $58.68. Biogen Idec rose $.70 or 1.3 percent, to $52.95. Celgene rose $.55 or .9 percent, to $59.56. Gilead Sciences rose $.34 or .8 percent, to $40.90.
Read more »
NEW YORK (AP) -- Shares of some top biotechnology companies were down at the close of trading: Amgen fell $.45 or .8 percent, to $58.43. Biogen Idec fell $.34 or .6 percent, to $52.25. Celgene fell $.80 or 1.3 percent, to $59.01. Gilead Sciences fell $1.11 or 2.7 percent, to $40.56.
Read more »
A biotech company uses recombinant DNA in the process of discovering, developing and manufacturing of a potential new drug.
Read more »